ClinicalTrials.gov
public full text
Public Domain
Reducing Breathlessness With Dronabinol in COPD Patients
This clinical trial examines whether Dronabinol, which contains the synthetic psychoactive compound tetrahydrocannabinol (THC), can alleviate severe breathlessness in patients with severe and very severe chronic obstructive pulmonary disease (COPD).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effect of Cannabis on Dementia Related Agitation and Aggression#1044213
- Is Patients With Pulmonary Disease Benefit a Program With Yogic Exercises?#1151247
- Study of Dronabinol Treatment for Depression and/or Anxiety in Older Patients#1030720
- Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe / Very Severe COPD#838583
- Assessment of Stress Levels and Depressive and Anxiety Symptoms in Patients With COPD#1127732
Record · ID 916622
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive